Literature DB >> 25067907

Mindfulness-based 'third wave' cognitive and behavioural therapies versus treatment as usual for depression.

Rachel Churchill1, Theresa Hm Moore1, Philippa Davies1, Deborah Caldwell2, Hannah Jones3, Glyn Lewis2, Vivien Hunot1.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To examine the effectiveness and acceptability of all third wave CBT approaches compared with treatment as usual/waiting list/attention placebo control conditions for acute depression.To examine the effectiveness and acceptability of different third wave CBT approaches (ACT, compassionate mind training, functional analytic psychotherapy, meta-cognitive therapy, dialectical behaviour therapy, MBCT, extended behavioural activation and meta-cognitive therapy) compared with treatment as usual/waiting list/attention placebo control conditions for acute depression.To examine the effectiveness and acceptability of all third wave CBT approaches compared with different types of comparator (standard care, no treatment, waiting list, attention placebo) for acute depression.

Entities:  

Year:  2010        PMID: 25067907      PMCID: PMC4110888          DOI: 10.1002/14651858.CD008705

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  57 in total

1.  Self-reported medication use for older people in England and Wales.

Authors:  Y F Chen; M E Dewey; A J Avery
Journal:  J Clin Pharm Ther       Date:  2001-04       Impact factor: 2.512

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  Including older people in clinical research.

Authors:  Marion E T McMurdo; Miles D Witham; Neil D Gillespie
Journal:  BMJ       Date:  2005-11-05

4.  Cognitive-behavioural therapies: achievements and challenges.

Authors:  Brandon A Gaudiano
Journal:  Evid Based Ment Health       Date:  2008-02

Review 5.  Efficacy of the third wave of behavioral therapies: a systematic review and meta-analysis.

Authors:  Lars-Göran Ost
Journal:  Behav Res Ther       Date:  2007-12-23

6.  Treating depression in general practice: factors affecting patients' treatment preferences.

Authors:  R Churchill; M Khaira; V Gretton; C Chilvers; M Dewey; C Duggan; A Lee
Journal:  Br J Gen Pract       Date:  2000-11       Impact factor: 5.386

7.  Excess mortality in depression: a meta-analysis of community studies.

Authors:  Pim Cuijpers; Filip Smit
Journal:  J Affect Disord       Date:  2002-12       Impact factor: 4.839

Review 8.  Australian and New Zealand clinical practice guidelines for the treatment of depression.

Authors:  Peter Ellis
Journal:  Aust N Z J Psychiatry       Date:  2004-06       Impact factor: 5.744

Review 9.  Sertraline versus other antidepressive agents for depression.

Authors:  Andrea Cipriani; Teresa La Ferla; Toshi A Furukawa; Alessandra Signoretti; Atsuo Nakagawa; Rachel Churchill; Hugh McGuire; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

10.  Prevalence of cognitive impairment: results from the MRC trial of assessment and management of older people in the community.

Authors:  Greta Rait; Astrid Fletcher; Liam Smeeth; Carol Brayne; Susan Stirling; Maria Nunes; Elizabeth Breeze; Edmond Siu-Woon Ng; Chris J Bulpitt; Dee Jones; Alistair J Tulloch
Journal:  Age Ageing       Date:  2005-05       Impact factor: 10.668

View more
  2 in total

Review 1.  Behavioural therapies versus other psychological therapies for depression.

Authors:  Kiyomi Shinohara; Mina Honyashiki; Hissei Imai; Vivien Hunot; Deborah M Caldwell; Philippa Davies; Theresa H M Moore; Toshi A Furukawa; Rachel Churchill
Journal:  Cochrane Database Syst Rev       Date:  2013-10-16

Review 2.  Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.

Authors:  Georgina R Cox; Caroline A Fisher; Stefanie De Silva; Mark Phelan; Olaoluwa P Akinwale; Magenta B Simmons; Sarah E Hetrick
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.